Oliver W. Press M.D. Ph.D is the Acting Director of the Clinical Research Division, an Acting Senior Vice President of the Fred Hutch (FHCRC), a Professor of Medicine and Adjunct Professor of Bioengineering at the University of Washington (UW).
Dr. Press is involved in laboratory research, clinical research, patient care and mentorship. He leads the Antibody Research Group at FHCRC which conducts both laboratory and clinical research using immunotherapeutic approaches to treat lymphomas, leukemias, and myelomas in a wide variety of cellular assays, mouse models and human clinical trials. He is currently the P.I. on four NIH R01 grants and an NIH P01 grant and has published more than 200 peer-reviewed research articles. He also cares for patients in his continuity clinics and serves as a transplant attending at the SCCA.
Dr. Press has been the PhD advisor for many UW graduate students, served as Associate Director of the MD-PhD program at the UW for 16 years, and has been one of the most active mentors in the Hematology/Oncology fellowship program.
Dr. Press is the recipient of the Dr. Penny E. Petersen Memorial Chair of Lymphoma Research at FHCRC. He is currently the Co-Director of the UW Center for Intracellular Delivery of Biologics, Co-Director of the Training Program in Nanotechnology and Physical Sciences in Cancer Research at the UW, Chair of the American Society of Hematology Scientific Committee on Lymphoid Neoplasia, and Co-Chair of the Lymphoma Steering Committee of the National Cancer Institute.